Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 20/20 | 0.88 |
| ▸ | AKT2 | P31751 | 15/20 | 0.88 |
| ▸ | AKT3 | Q9Y243 | 15/20 | 0.88 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.88 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27227203 | 1.00 | AKT1 (0.88) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL30574963 | 0.94 | AKT1 (1.00) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL27226703 | 0.94 | AKT1 (0.91) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL2176743 | 0.94 | AKT1 (1.00) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL30815384 | 0.94 | AKT1 (0.91) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL30802341 | 0.91 | AKT1 (0.88) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL2190097 | 0.91 | AKT1 (0.94) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL2174059 | 0.90 | AKT1 (0.87) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL2174671 | 0.89 | AKT1 (1.00) | AKT1AKT2AKT3CYP2C9CYP2C8 | |
| SCHEMBL2174099 | 0.89 | AKT1 (0.82) | AKT1AKT2AKT3CYP2C9CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594318-A1 | AKT1 MODULATORS | Alterome Therapeutics, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024073371-A1 | AKT1 MODULATORS | ALTEROME THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |